The human symbiont Mucispirillum schaedleri: causality in health and disease S Herp, AC Durai Raj, M Salvado Silva, S Woelfel, B Stecher Medical microbiology and immunology 210 (4), 173-179, 2021 | 77 | 2021 |
Quasi-essentiality of RNase Y in Bacillus subtilis is caused by its critical role in the control of mRNA homeostasis M Benda, S Woelfel, P Faßhauer, K Gunka, S Klumpp, A Poehlein, ... Nucleic Acids Research 49 (12), 7088-7102, 2021 | 16 | 2021 |
Systemic and T cell‐associated responses to SARS‐CoV‐2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of … S Woelfel, J Dütschler, M König, N Graf, V Oikonomou, C Krieger, ... Alimentary pharmacology & therapeutics 57 (1), 103-116, 2023 | 8 | 2023 |
Pulsed antibiotic treatments of gnotobiotic mice manifest in complex bacterial community dynamics and resistance effects PC Münch, C Eberl, S Woelfel, D Ring, A Fritz, S Herp, I Lade, R Geffers, ... Cell Host & Microbe 31 (6), 1007-1020. e4, 2023 | 3 | 2023 |
Complete genome sequence of Helicobacter pylori B128 7.13 and a single‐step method for the generation of unmarked mutations EM Dawson, KA Dunne, EJ Richardson, J Praszkier, D Alfawaz, S Woelfel, ... Helicobacter 24 (4), e12587, 2019 | 2 | 2019 |
STAR SIGN study: Evaluation of COVID‐19 vaccine efficacy against the SARS‐CoV‐2 variants BQ. 1.1 and XBB. 1.5 in patients with inflammatory bowel disease S Woelfel, J Dütschler, M König, A Dulovic, N Graf, D Junker, ... Alimentary pharmacology & therapeutics 58 (7), 678-691, 2023 | | 2023 |
Pulsed Antibiotic Treatments of Gnotobiotic Mice Manifests in Complex Community Dynamics and Resistance Effects PC Münch, C Eberl, D Ring, S Woelfel, A Fritz, S Herp, I Lade, R Geffers, ... Available at SSRN 4149957, 0 | | |